These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3521207)

  • 41. Streptokinase therapy in the routine management of deep venous thrombosis in the lower extremities. A retrospective study of phlebographic results and therapeutic complications.
    Ott P; Eldrup E; Oxholm P; Vestergård A; Knudsen JB
    Acta Med Scand; 1986; 219(3):295-300. PubMed ID: 3706003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. North Baden venous lysis trial (NBVL): multicentre prospective randomized phlebographically controlled trial on the effect of ultra-high versus conventional doses of streptokinase in fresh leg-pelvis venous thromboses.
    Heinrich F; Heinrich U
    Vasc Med; 1998; 3(2):87-94. PubMed ID: 9796070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis.
    O'Meara JJ; McNutt RA; Evans AT; Moore SW; Downs SM
    N Engl J Med; 1994 Jun; 330(26):1864-9. PubMed ID: 8196729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.
    Sagar S; Nairn D; Stamatakis JD; Maffei FH; Higgins AF; Thomas DP; Kakkar VV
    Lancet; 1976 May; 1(7970):1151-4. PubMed ID: 58199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.
    Warwick D; Harrison J; Glew D; Mitchelmore A; Peters TJ; Donovan J
    J Bone Joint Surg Am; 1998 Aug; 80(8):1158-66. PubMed ID: 9730125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sequelae of deep venous thrombosis, 5-year follow-up of 341 patients].
    Widmer MT; Zemp E; Voëlin R; Brandenberg E; Da Silva A
    Phlebologie; 1987; 40(4):915-21. PubMed ID: 3447194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of deep-vein thrombosis--a random trial.
    Kakkar VV; Flanc C; O'Shea M; Flute P; Howe CT; Clarke MB
    Br J Surg; 1968 Nov; 55(11):858. PubMed ID: 4879792
    [No Abstract]   [Full Text] [Related]  

  • 48. Catheter-directed thrombolysis following vena cava filtration for severe deep venous thrombosis.
    Tarry WC; Makhoul RG; Tisnado J; Posner MP; Sobel M; Lee HM
    Ann Vasc Surg; 1994 Nov; 8(6):583-90. PubMed ID: 7865398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deep venous thrombosis treated with a standard dosage of streptokinase.
    Olow B; Johanson C; Andersson J; Eklöf B
    Acta Chir Scand; 1970; 136(3):181-9. PubMed ID: 5518309
    [No Abstract]   [Full Text] [Related]  

  • 50. Acute iliac vein thrombosis in pregnancy treated successfully by streptokinase lysis: a case report.
    Henrich W; Schmider A; Henrich M; Dudenhausen JW
    J Perinat Med; 2001; 29(2):155-7. PubMed ID: 11344675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The duration of oral anticoagulation after deep vein thrombosis. A randomized study.
    Schulman S; Lockner D; Juhlin-Dannfelt A
    Acta Med Scand; 1985; 217(5):547-52. PubMed ID: 3895828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of streptokinase and heparin on patients with deep venous thrombosis. A coded examination.
    Robertson BR; Nilsson IM; Nylander G; Olow B
    Acta Chir Scand; 1967; 133(3):205-15. PubMed ID: 6030168
    [No Abstract]   [Full Text] [Related]  

  • 53. Venous function, evaluated by foot volumetry, in patients with a previous deep venous thrombosis, treated with streptokinase. Preliminary results.
    Norgren L; Widmer LK
    Vasa; 1978; 7(4):412-4. PubMed ID: 726608
    [No Abstract]   [Full Text] [Related]  

  • 54. Prolonged bleeding time as a marker of venous clot lysis during streptokinase therapy.
    Hirsch DR; Reis SE; Polak JF; Donovan BC; Goldhaber SZ
    Am Heart J; 1991 Oct; 122(4 Pt 1):965-71. PubMed ID: 1927883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism.
    Tibbutt DA; Davies JA; Anderson JA; Fletcher EW; Hamill J; Holt JM; Thomas ML; Lee G; Miller GA; Sharp AA; Sutton GC
    Br Med J; 1974 Mar; 1(5904):343-7. PubMed ID: 4594580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A 6-month venographic follow-up in 164 patients with acute deep vein thrombosis.
    Holmström M; Lindmarker P; Granqvist S; Johnsson H; Lockner D
    Thromb Haemost; 1997 Aug; 78(2):803-7. PubMed ID: 9268175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Streptokinase treatment of deep venous thrombosis and the postthrombotic syndrome. Follow-up evaluation of venous function.
    Albrechtsson U; Anderson J; Einarsson E; Eklöf B; Norgren L
    Arch Surg; 1981 Jan; 116(1):33-7. PubMed ID: 7469730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet scintigraphy results of heparin versus streptokinase treatment in acute deep vein thrombosis.
    Silistreli E; Bekis R; Serbest O; Arslan G; Ulker O; Catalyurek H; Acikel U
    Scand Cardiovasc J; 2004 Dec; 38(6):380-2. PubMed ID: 15804807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The treatment of deep vein thrombosis.
    Flute PT; Kakkar VV; Flanc C; O'Shea MJ; Howe CT; Clarke MB
    J Clin Pathol; 1969 May; 22(3):372-3. PubMed ID: 4891484
    [No Abstract]   [Full Text] [Related]  

  • 60. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D
    N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.